The research, published in the September issue of Immunity, is part of a broad reverse - engineering
effort by scientists around the world to use antibodies isolated from
HIV - infected people to guide the
development of a successful
vaccine.
In the piece, the authors note that behavioral, cultural and legal factors have hindered
HIV prevention and treatment
efforts and explain why those factors necessitate the
development of an
HIV vaccine.